Recombinant human coagulation factor VIIa(Beijing Northland Biotech)

重组人凝血因子VIIa（北京诺思兰德生物）

Report date: 2025/10/28 17:38:29

Base Information

Drug NameRecombinant human coagulation factor VIIa(Beijing Northland Biotech)
Drug Alias NameNL-201NL201
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factor
Mechanisms of ActionFactor VIIa modulators
TargetsCoagulation factor VII
Therapy Area/IndicationsHemophilia BHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Northland Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Northland Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsHemophilia BHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A